Australia markets open in 5 hours 11 minutes

Prescient Therapeutics Limited (PTX.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.1400-0.0100 (-6.67%)
At close: 04:10PM AEDT
Currency in AUD

Valuation measures4

Market cap (intra-day) 111.57M
Enterprise value 95.62M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)6.23
Enterprise value/revenue -137.24
Enterprise value/EBITDA -18.71

Trading information

Stock price history

Beta (5Y monthly) 0.71
52-week change 3-39.13%
S&P500 52-week change 3-15.72%
52-week high 30.2600
52-week low 30.1150
50-day moving average 30.1599
200-day moving average 30.1645

Share statistics

Avg vol (3-month) 3603.96k
Avg vol (10-day) 3293.02k
Shares outstanding 5719.81M
Implied shares outstanding 6N/A
Float 8535.11M
% held by insiders 114.86%
% held by institutions 10.08%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:20
Last split date 302 Dec 2014

Financial highlights

Fiscal year

Fiscal year ends 30 June 2022
Most-recent quarter (mrq)30 June 2022

Profitability

Profit margin -270.85%
Operating margin (ttm)-275.76%

Management effectiveness

Return on assets (ttm)-16.88%
Return on equity (ttm)-27.52%

Income statement

Revenue (ttm)1.89M
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)94.70%
Gross profit (ttm)1.89M
EBITDA -5.21M
Net income avi to common (ttm)-5.12M
Diluted EPS (ttm)-0.0080
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)12.28M
Total cash per share (mrq)0.02
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)17.61
Book value per share (mrq)0.03

Cash flow statement

Operating cash flow (ttm)-4.31M
Levered free cash flow (ttm)-2.4M